Actavis plc’s (NYSE:ACT) new drug application (NDA) for its antibiotic candidate, ceftazidime-avibactam, has been accepted for review by the FDA. Actavis is looking to get ceftazidime-avibactam approved for the treatment of patients with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI), including those caused by multi-drug resistant gram-negative bacterial pathogens. Actavis plc (NYSE:ACT) belongs to Healthcare sector. Its net profit margin is 0.60% and weekly performance is 2.64%. On last trading day company shares ended up $232.97. Actavis plc (NYSE:ACT) distance from 50-day simple moving average (SMA50) is 6.48%.

On 2 Sep 2014 Borderfree (NASDAQ:BRDR), a market leader in international cross-border ecommerce solutions, today announced that Michael DeSimone, Chief Executive Officer, and Ed Neumann, Chief Financial Officer, will present at the Credit Suisse 5th Annual Small & Mid Cap Conference, to be held at The Waldorf Astoria in New York on Tuesday, September 16 at 1:50 PM ET. Borderfree, Inc. (NASDAQ:BRDR) shares moved down -0.78% in last trading session and ended the day at $14.05. BRDR Gross Margin is 33.80% and its return on assets is -2.70%. Borderfree, Inc. (NASDAQ:BRDR) quarterly performance is -11.64%.

On July 28, 2014, Sohu.com Inc. (NASDAQ:SOHU) announced its unaudited financial results for the second quarter ended June 30, 2014. A copy of the press release issued by the registrant regarding the foregoing is filed herewith as Exhibit 99.1 and is incorporated herein by reference. On 08 September, Sohu.com Inc. (NASDAQ:SOHU) shares moved down -0.83% and was closed at $56.02. SOHU EPS growth in last 5 year was -16.00%. Sohu.com Inc. (NASDAQ:SOHU) year to date (YTD) performance is -23.19%.

On 2 Sep 2014 Rowan Companies plc’s (NYSE:RDC) share price rose by 1.5% on the news of it receiving the delivery of its second ultra deepwater drillship, Rowan Resolute. Rowan Companies plc (NYSE:RDC) ended the last trading day at $28.67. Company weekly volatility is calculated as 1.83%and price to cash ratio as 2.86. Rowan Companies plc (NYSE:RDC) showed a weekly performance of -5.44%.

On 7 Aug 2014 Platform Specialty Products Corporation (NYSE:PAH), a global specialty chemicals company, announced today that it has entered into an amendment to its credit agreement. Platform Specialty Products Corporation (NYSE:PAH) shares moved down -1.58% in last trading session and ended the day on $26.77. Platform Specialty Products Corporation (NYSE:PAH) quarterly performance is -2.44%.